Prudential Financial
CHRS icon

Prudential Financial’s Coherus Oncology CHRS Stock Holding History

Prudential Financial’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.2K Buy
20,835
+4,740
+29% +$7.74K ﹤0.01% 2461
2026
Q1 		$27.2K Buy
+16,095
New +$28.6K ﹤0.01% 2370
2025
Q4 		– Sell
-14,980
Closed -$24.6K – 2253
2025
Q3 		$24.6K Hold
14,980
– – ﹤0.01% 2391
2025
Q2 		$10.9K Buy
+14,980
New +$12.9K ﹤0.01% 2420
2023
Q3 		– Sell
-82,529
Closed -$352K – 2609
2023
Q2 		$352K Buy
82,529
+19,642
+31% +$116K ﹤0.01% 2246
2023
Q1 		$430K Sell
62,887
-2,800
-4% -$21.7K ﹤0.01% 2140
2022
Q4 		$520K Buy
65,687
+55
+0.1% +$423 ﹤0.01% 2005
2022
Q3 		$631K Sell
65,632
-500
-0.8% -$5.06K ﹤0.01% 1966
2022
Q2 		$479K Sell
66,132
-560
-0.8% -$4.87K ﹤0.01% 2156
2022
Q1 		$861K Sell
66,692
-1,823
-3% -$23.2K ﹤0.01% 1941
2021
Q4 		$1.21M Sell
68,515
-1,369
-2% -$23.9K ﹤0.01% 1792
2021
Q3 		$1.23M Sell
69,884
-4,258
-6% -$62.4K ﹤0.01% 1697
2021
Q2 		$1.02M Sell
74,142
-74,804
-50% -$1.06M ﹤0.01% 1823
2021
Q1 		$2.18M Sell
148,946
-102,510
-41% -$1.74M ﹤0.01% 1420
2020
Q4 		$4.37M Buy
251,456
+41,764
+20% +$744K 0.01% 1063
2020
Q3 		$3.85M Buy
209,692
+135,786
+184% +$2.53M 0.01% 1023
2020
Q2 		$1.32M Buy
+73,906
New +$1.25M ﹤0.01% 1518

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Prudential Financial's CHRS Position: Q2 2026 in Review

Prudential Financial increased its Coherus Oncology (CHRS) stake by 29% in Q2 2026, buying an estimated $7.74K and bringing the position to 20,835 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

Prudential Financial first reported a position in CHRS in Q2 2020 and has held it in 17 quarters since. The position peaked at $4.37M in Q4 2020. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Prudential Financial held 20,835 shares of Coherus Oncology worth $29.2K as of Q2 2026.
  • Prudential Financial bought 4,740 Coherus Oncology shares in Q2 2026, an estimated $7.74K.
  • Coherus Oncology made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2461 holding.
  • Prudential Financial first reported a position in Coherus Oncology in Q2 2020 and has held it in 17 quarters since.
  • Prudential Financial's Coherus Oncology position peaked at $4.37M in Q4 2020.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.